The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
Several technologies for hemoglobinopathies are being transferred to commercial partners
SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Investment to expand manufacturing and global medicine supply capacity
Takeda will seek an external partner to leverage its cell therapy platform technologies
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Subscribe To Our Newsletter & Stay Updated
